Pulse Biosciences Inc expected to post a loss of 51  cents a share - Earnings Preview

Pulse Biosciences

18/02/2022 11:04

* Pulse Biosciences Inc  PLSE.OQ   PLSE.O  is expected
to show a
rise in quarterly revenue when it reports  results on February
21 (estimated). 
    * The Hayward California-based  company is expected to
report
revenue of $872 thousand, according to the mean estimate from 3
analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for Pulse Biosciences
Inc is
for a loss of 51 cents per share. For the same quarter last
year, the company reported a loss of 54 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Pulse
Biosciences
Inc is $20​, about 69.6% above​ its last closing price
of $6.09. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  -0.53       -0.53      -0.48     Beat    10
 Jun. 30 2021  -0.68       -0.69      -0.58     Beat    16.3
 Mar. 31 2021  -0.49       -0.49      -0.71     Missed  -43.4​
 Dec. 31 2020  -0.45       -0.45      -0.54     Missed  -20
 ​​Sep.        -0.44       -0.44      -0.51     Missed  -15.9
 30 2020                                                
 Jun. 30 2020  -0.50       -0.50      -0.53     Missed  -6​
 Mar. 31 2020  -0.47       -0.47      -0.57     Missed  -21.3
 Dec. 31 2019              -0.61      -0.66     Missed  -8.2
 This summary was machine generated February 18 at 11:04 GMT. 
All figures in US dollars  unless otherwise stated